Synevo Ukraine

What Synevo Ukraine does

Synevo Ukraine (legal entity TOV 'Synevo Ukraina') is the largest medical laboratory network in Ukraine, operating 360+ physical patient service branches across 164 settlements and 8 centralized laboratories in Kyiv, Vinnytsia, Lviv, Chernivtsi, Odesa, Kherson, Dnipro, and Kharkiv. Founded in 2007 and headquartered in Kyiv, the company is a wholly-owned subsidiary of Swedish medical holding Medicover (Stockholm Stock Exchange: MCOV), which listed Synevo as the first Ukrainian medical company traded on an international exchange in 2017. Synevo employs over 2,500 staff and in 2025 served more than 4 million clients while performing 25.5 million tests across a menu of 1,200+ test types.

The platform is built on automated analyzers from leading global manufacturers (Roche Cobas 8000, Cobas PRO; Abbott Alinity i, ARCHITECT i2000SR; Sysmex XN-2000, CN-6000; BD SurePath and FocalPoint GS; Thermo Fisher Phadia 250; Bruker MALDI Biotyper; ZEISS Axioscope 5) connected to a centralized laboratory information system, with ISO 15189:2022 certification and participation in international quality control (RIQAS, RfB, INSTAND, Labquality). Recent product investment is centered on AI-augmented diagnostics — the Cytological Passport combines liquid-based cytology, BD FocalPoint AI imaging, and ZEISS expert microscopy — and Tissue Diagnostics offering immunohistochemistry with 200+ validated antibodies.

Synevo monetizes through three primary streams: (1) one-time pay-as-you-go laboratory testing for individual consumers ordered online or in-branch, with sample prices ranging from routine panels to 1,980 UAH pathomorphology tests; (2) a subscription/wallet program (RESULT Synevo) offering 20% bonus value on prepaid 1,000-5,000 UAH plans, generating annual recurring cash; and (3) B2B corporate and clinic accounts via a dedicated portal (corporate.synevo.ua) with MIS integration, business analytics, and negotiated pricing. In 2024 the company added a public-pay channel via a partnership with the National Health Service of Ukraine (NSZU) for government-reimbursed tests.

Name

Synevo Ukraine

Legal name

Товариство з обмеженою відповідальністю «Сінево Україна»

Website

https://new.synevo.ua

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

Synevo Ukraine is the largest medical laboratory network in Ukraine, operating 360+ branches across 164 settlements and 8 centralized labs. Wholly-owned by Sweden's Medicover, it serves over 4 million clients annually with 1,200+ test types, B2C retail testing, B2B clinic/corporate accounts, and an NSZU government channel.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industry

Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Medical laboratory diagnostics
• Clinical pathology services
• Cytology screening services
• Immunohistochemistry diagnostics
• Preventive health screening

Headquarters

HQ city

Kyiv

HQ country

Ukraine

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Laboratory Testing Services: One-time laboratory diagnostic tests for patients. Over 1,200 types of tests performed across 8 major laboratories. Tests ordered individually or as packages via online ordering or at branches.
2. Subscription/Wallet Program (Підписка): Prepaid bonus program where customers purchase subscription plans (1,000-5,000 UAH) receiving 20% bonus on amounts, redeemable for laboratory tests at 1 bonus = 1 UAH rate. Annual billing cycle.
3. Corporate/B2B Services: Laboratory services for medical clinics and corporate clients including employee health checkups, automated MIS integration, and corporate account management.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Synevo Ukraine operates a national medical laboratory network performing more than 1,200 diagnostic test types across 8 centralized laboratories and over 360 branches in 164 Ukrainian settlements. It serves individual consumers through retail branch visits and online ordering, and serves corporate clients and medical clinics through a dedicated B2B portal with medical information system integration. The company is part of Swedish medical holding Medicover and offers specialized services including AI-assisted cervical cancer screening (Cytological Passport) and tissue diagnostics with immunohistochemistry.

Product overview

Synevo Ukraine is a European medical laboratory network offering a unified diagnostic services platform with multiple integrated modules. The core offering is medical laboratory testing services performing 1200+ types of tests across 8 regional laboratories and 360+ branches. This core platform is enhanced by specialized modules including the AI-powered Cytological Passport for cervical cancer screening (combining BD SurePath liquid cytology with automated BD FocalPoint GS AI analysis and ZEISS microscopy), Tissue Diagnostics (pathohistology, immunohistochemistry with 200+ antibodies, cytomorphology, second opinions, and intraoperative studies), and Subscription/Wallet services for discounted analysis payments. Additional modules include B2B corporate services with MIS integration capabilities and customer loyalty programs. The company operates within the international Medicover holding (Swedish healthcare diagnostics provider listed on Stockholm Stock Exchange).

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory Testing Services (Лабораторні послуги) Core medical laboratory diagnostic services performing over 1,200 types of tests across 8 modern laboratories in Kyiv, Vinnytsia, Lviv, Chernivtsi, Odesa, Kherson, Dnipro, and Kharkiv, supported by 360+ branch sample-collection points in 164 settlements across Ukraine. Tests are available to individual consumers via online ordering (synevo.ua), mobile app, or in-branch visits, delivering 25.5 million tests to 4+ million clients in 2025.
• Cytological Passport (Цитологічний паспорт) Innovative cervical cancer screening solution combining BD SurePath liquid-based cytology (FDA approved) with automated AI analysis via BD FocalPoint GS Imaging System and expert cytology verification on ZEISS Axioscope 5. Delivers structured digital reports with Bethesda 2014 classification and real cell images. Demonstrates +9.2% sensitivity for ASC-H, +9.8% for HSIL, and +24.5% for cervical cancer detection versus traditional methods, with 27% reduction in turnaround time.
• Tissue Diagnostics (Тканинна діагностика) Advanced pathomorphological diagnostic services including pathohistological research, immunohistochemical (IHC) studies using over 200 validated antibodies, cytomorphological studies using LBC method, second opinion consultations, and intraoperative express diagnostics. Performed using automated Epredia/Thermo Fisher and ZEISS equipment following CAP and Royal College of Pathologists protocols.
• Subscription Service (Підписка / РЕЗУЛЬТАТ Сінево) Prepaid bonus wallet subscription service that converts payments to bonus points with 20% extra value, redeemable for laboratory tests at 1 bonus = 1 UAH rate. Available in tariff plans of 1,000 UAH (1,200 bonuses), 3,000 UAH (3,600 bonuses), and 5,000 UAH (6,000 bonuses) on annual billing.
• Corporate Services (Бізнес-кабінет) B2B laboratory services for medical clinics and corporate clients, including automated pre- and post-analytical laboratory process integration with client medical information systems (MIS), a dedicated corporate account portal (corporate.synevo.ua), online ordering, business analytics, and partner loyalty programs. Covers employee health checkups (Check Up programs) and clinic patient referral testing.
• Home Nurse Visit Service (Візит медсестри) Mobile sample collection service where a nurse visits the patient's location (home or office) for sample collection, eliminating the need to visit a branch. Targeted at patients with mobility limitations, time-constrained professionals, and busy families.

Quantifiable outcome

• 25.5 million tests performed in 2025
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

14 partnerships are on record, tiered core and flagship.

• National Health Service of Ukraine (НСЗУ)coreChannel Partner/ Reseller/ Distributor · 1 January 2024Synevo partners with National Health Service of Ukraine to provide free laboratory tests under government healthcare program. Patients can access covered tests at Synevo branches through NSZU program.
• Territorial Defense (ТрО) - Laboratory PartnercoreStrategic or Co-development Partner · 1 January 2022Synevo received official status as 'Laboratory Partner of Territorial Defense' in 2022, providing diagnostic services to military personnel.
• Medicover (Sweden)flagshipStrategic or Co-development Partner · 1 January 2007Synevo Ukraine is part of Swedish medical holding Medicover, which provides diagnostic services in 16 European countries. Medicover IPO on Stockholm Stock Exchange in 2017. Synevo is the first Ukrainian medical company with shares listed on international exchange. Medicover operates 117 modern laboratories globally, 8 of which are in Ukraine.
• Roche Diagnostics (Switzerland)coreTechnology or IntegrationEquipment supplier for automated biochemical and immunochemical analyzers. Synevo uses Cobas 8000, Cobas PRO, Cobas c513, Cobas P512 pre-analytical systems, Cobas Connection Modules (CCM), Cobas s513 from Roche.
• Abbott (USA)coreTechnology or IntegrationEquipment supplier providing Alinity i, ARCHITECT i2000SR immunochemical analyzers, RealTime PCR systems m2000rt/m2000sp for infectious disease diagnostics.
• Sysmex (Japan)coreTechnology or IntegrationEquipment supplier for hematology (Sysmex XN-2000, Sysmex CN-6000 hemostasis), urinalysis (Sysmex UN-5000), and digital microscopy (Sysmex CellaVision DM 96).
• Becton Dickinson (USA)coreTechnology or IntegrationSupplier of BD SurePath liquid-based cytology system, BD FocalPoint GS AI imaging system for cervical cancer screening, BD PrepStain slide preparation system, BD PHOENIX M50 microbiology identification system.
• Thermo Fisher Scientific (USA)coreTechnology or IntegrationSupplier of Phadia 250 laboratory systems for allergy and autoimmune diagnostics using ImmunoCAP and EliA technologies. Equipment for histopathology processing.
• Bio-Rad (USA)coreTechnology or IntegrationSupplier of IH-1000 immunohematology testing systems for blood group determination (ABO, Rh, Kell systems).
• Euroimmun (Germany)coreTechnology or IntegrationSupplier of EUROIMMUN Analyzer I for infectious disease and allergy testing via ELISA, EUROLabWorkstation ELISA, and EuroBlotOne for immunoblotting diagnostics.
• Bruker (Germany)coreTechnology or IntegrationSupplier of MALDI Biotyper sirius IVD System for rapid automated microorganism identification via MALDI-TOF mass spectrometry (results in up to 15 minutes).
• ZEISS (Germany)coreTechnology or IntegrationEquipment supplier for tissue diagnostics microscopy - ZEISS Axioscope 5 for expert verification of cytology and histopathology specimens.
• RIQAS (UK)coreOthersExternal quality assessment program (UK) - Synevo participates in international quality control alongside 50,000+ medical laboratories from 139 countries.
• INSTAND / DGKL-RfB (Germany)coreOthersGerman external quality assessment organizations for laboratory proficiency testing.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/synevo-ua

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synevo Ukraine